Related by context. All words. (Click for frequent words.) 57 Somatuline R Autogel 57 Amplimexon 57 CAMPATH 56 elvucitabine 56 RhuDex ® 56 telaprevir VX 55 ofatumumab HuMax CD# 55 Hyphanox 55 HuMax CD4 55 CIMZIA ™ 55 pradefovir 54 HuMax 54 CD# monoclonal antibody 54 ATL/TV# 54 Rodobens 54 Copegus ribavirin 54 GHIS 54 Allovectin 7 R 54 product Fentanyl TAIFUN 54 Astion Pharma 53 Nuvion 53 β2 53 HBeAg negative 53 UPLYSO 53 Somatuline R Depot 53 otelixizumab 53 E1 INT TM 53 Traficet EN 53 Tech Ueno 53 Factor VIIa 53 BIO Pte Ltd 53 selective adenosine 53 formerly LymphoStat B 53 micafungin 53 TRO# 53 AutovaxID TM 53 A3 adenosine receptor 53 valtorcitabine 53 Bicifadine 53 DiaPep# 53 HCD# [002] 53 Guanilib 53 fluoropyrimidine 53 Æterna Zentaris 53 L methionine 53 T#M mutation 53 Alferon N Injection 53 Aloxi injection 53 beta 1a 52 Fibrillex TM 52 HBeAg negative chronic hepatitis 52 Phase III VELCADE 52 reslizumab 52 dacetuzumab 52 Lovaxin 52 Corgentin 52 SARcode 52 JAK inhibitors 52 sargramostim 52 Albugon 52 Aflibercept 52 Vitaxin 52 ATL# [001] 52 ImmuneRegen BioSciences 52 alemtuzumab Campath 52 effector function 52 SCCHN 52 plus DOXIL 52 dextromethorphan quinidine 52 Epratuzumab 52 INC# 52 immunoglobulin Ig 52 Azilect ® 52 IV Busulfex 52 VGV 1 52 Interferon alfa 52 Alocrest 52 PSMA ADC 52 CD3 monoclonal antibody 52 RhuDex TM 52 MYDICAR 52 humanized monoclonal antibody 52 XmAb# 51 HuMax CD# 51 valopicitabine 51 LB# [003] 51 HuLuc# 51 Telintra 51 CCR5 receptor antagonist 51 bardoxolone 51 rilonacept 51 Subphase 51 Zirgan 51 ITAU 51 CANCIDAS 51 PEG IFN 51 VQD 51 TG# [003] 51 antibody MAb 51 KNS # 51 MCMV 51 controlled multicenter Phase 51 HyACT 51 ATryn ® 51 diarrhea predominant irritable 51 chemotherapy induced neutropenia 51 GetGoal 51 Xanafide 51 Biocoral 51 cat dander allergy 51 CIMZIA TM 51 terlipressin 51 mertansine 51 Adnavance 51 myeloproliferative 51 ceftaroline 51 JAK inhibitor 51 ACZ# 51 Daclizumab 51 synthetic retinoid 51 atacicept 51 Cardio Vascu Grow 51 TRISENOX ® 51 MAGE A3 ASCI 51 PRTX 51 HuMax TAC 51 glucokinase activator 51 AGGRASTAT R 51 AMEVIVE 51 Cx# [002] 51 STELARA 51 Catena ® 51 LUCASSIN 51 ceftazidime 51 RYDER SYSTEM 51 fusion inhibitor 51 Aplidin R 51 clivatuzumab 51 immatics 51 compound Homspera 51 EndoTAG TM -1 51 Prednisporin 51 SYGNIS 51 Nanobody 51 Kyowa Kirin 51 Propofol IDD D 51 posaconazole 51 ularitide 51 Insegia 51 GSK '# 51 constipation predominant irritable bowel 51 virotherapy 51 Prestara 51 VEGF receptor 50 torezolid 50 protein tyrosine phosphatase 50 murine monoclonal antibody 50 alemtuzumab MS 50 elotuzumab 50 AEGR 50 relapsed acute myelogenous 50 ovarian cancer chronic hepatitis 50 Neulasta R 50 Bezielle 50 Lodrane 50 MT# MEDI 50 beta interferons 50 Diamyd ® 50 dasatinib Sprycel 50 replicon 50 RELOVAIR ™ 50 Glypromate 50 INCB# [001] 50 anti CD3 monoclonal 50 ALN RSV program 50 HCV 50 HCV protease inhibitors 50 therapy Diamyd 50 targeted radiotherapeutic 50 KYN 50 MyVax 50 PDE4 inhibitor 50 Belerofon 50 Raptiva ® 50 outlicensing 50 balsalazide 50 T#I [002] 50 Fc fusion protein 50 BENLYSTA TM 50 NTDDS 50 AmpliMed 50 Symadex 50 HQK 50 induced angioedema 50 Symphony GenIsis 50 Oncaspar 50 Xyfid TM 50 NTx 50 cystinosis patients 50 Zalbin 50 Busulfex 50 systemic antifungal 50 Kepivance 50 Olerup SSP 50 HIV coinfected 50 imatinib mesylate Gleevec 50 vi vii 50 HyperAcute 50 Allovectin 7 50 OncoGel 50 gemtuzumab ozogamicin 50 Innodia 50 TYZEKA 50 Proprius Pharmaceuticals 50 STEDESA 50 investigational immunotherapy 50 Intarcia 50 chimeric antibodies 50 ABILIFY R 50 Shigamabs ® 50 daclizumab 50 Targretin 50 microplasmin Phase III 50 Xcellerated T Cells 50 Arcalyst 50 TH# [003] 50 Zorbtive TM 50 triciribine phosphate monohydrate 50 Symphogen 50 SinuNase 50 Pradefovir 50 Micromet BiTE 50 Abyara 50 FACTIVE tablets 50 Alferon N 50 include Healive 50 EnzymeRx 50 DUROS 50 Prulifloxacin 50 Pimavanserin 50 Urocidin TM 50 ARCALYST ® rilonacept 50 interferon γ 50 solithromycin 50 REGiMMUNE 50 Ocrelizumab 50 Dextofisopam 50 Doxil 50 midkine 50 TKM ApoB 50 Vegenics 50 RAPTIVA 50 maribavir 50 faropenem 50 caspofungin 50 pediatric acute lymphoblastic 50 AzaSite Plus 50 Revance 50 EndoTAG 50 Antiangiogenic 50 AVONEX ® 50 protease inhibitor PI 50 Fenoglide 50 Fludase 50 AltaRex 50 Zolinza 50 TELCYTA 50 CRMD 50 VIVACON AG 50 Virium 50 gemcitabine carboplatin 50 MVA BN R 50 BXT # 50 initiate Phase 1b 50 Dacogen decitabine 50 mg Proellex 50 W#HZV 50 TYKERB 50 piperacillin tazobactam 50 Behcet uveitis 50 AGGRASTAT ® 49 ZEFTERA TM Zevtera TM 49 FLT3 49 RITUXAN 49 Pyratine 6 49 immunotherapeutic vaccine 49 MYCAMINE 49 Otonomy 49 cetuximab Erbitux R 49 Stedesa 49 receptor antagonist 49 Archexin 49 Increlex TM 49 histone deacetylase HDAC inhibitor 49 HaptoGuard 49 TGR5 49 UVIDEM 49 colony stimulating factor 49 plerixafor 49 ZT Plus 49 NeoRecormon 49 KBS REIT 49 Onconase 49 IGN# 49 TheraCIM 49 Mycamine 49 BHT DNA 49 Ceflatonin R 49 Evoltra 49 PSMA antibody 49 EndoTAGTM 1 49 Tiuxetan 49 Nautilus Biotech 49 Loramyc R 49 Viramidine 49 cellular cytotoxicity 49 pomalidomide 49 NXL# 49 immune modulators 49 Sigma Tau Pharmaceuticals 49 tramiprosate Alzhemed TM 49 Amgen Neulasta R 49 Janus kinase 49 JAK3 49 Zollinger Ellison Syndrome 49 TASKi2 49 ZFP Therapeutics 49 liposome tumor 49 ß2 49 TREANDA 49 cathepsin 49 Increlex R 49 Sinuwave 49 fipamezole 49 Pliaglis 49 NNRTIs 49 oncolytic vaccine 49 ABLYNX 49 ZENPEP 49 INTEGRILIN 49 Arqule 49 Intravenous CP 49 TASKi3 49 SBIC LP 49 MAXY 49 somatostatin analog 49 BRAF V#E mutation 49 NK1 49 Gel Delivery Technology 49 Cellerix 49 alpha2 49 HBeAg 49 LEUKINE 49 ocrelizumab 49 favorable pharmacokinetic profile 49 EHT AGN 49 methylnaltrexone 49 Trisul 49 Nurel 49 SinuNase ™ 49 OZURDEX 49 vinorelbine tartrate 49 Shigamabs R 49 TFPI 49 Factor VEGF 49 Mestinon 49 treatment naive genotype 49 Solasia 49 rhMBL 49 Aplidin 49 IMiD 49 ViiV Healthcare 49 nucleoside naive patients 49 RNase H 49 hylan GF 49 immunomodulatory 49 Homspera 49 PAOD 49 ErbB3 49 Oxis International 49 Phase IIB 49 Benlysta belimumab 49 ARCALYST 49 Vancocin R 49 Onalta TM 49 COPEGUS R 49 NY ESO 49 peginterferon alfa 2a Pegasys 49 DepoDur 49 Zenapax 49 beta lactamase inhibitor 49 CRF1 receptor antagonist 49 ALLEGRA ® 49 BIBW 49 HBeAg positive 49 BLP# Liposome Vaccine 49 budesonide foam 49 Virulizin ® 49 Shigamabs 49 non nucleoside HCV 49 orally administered inhibitor 49 FOCALIN XR 49 Fentanyl Taifun 49 Chronic hepatitis C 49 Glufast 49 Phase IIb clinical trials 49 EP #R 49 proteasome inhibitor 49 OraTest R 49 EKC Cide 49 Virulizin R 49 CIMZIA TM certolizumab pegol 49 azithromycin ophthalmic solution 49 HBeAg + 49 BAL# [002] 49 Triolex 49 bispecific 49 Staccato alprazolam 49 Bairro Novo 49 LymphoStat B belimumab 49 DOXIL 49 OLUX 49 muscarinic 49 IgG1 antibody 49 genotype 1a 49 Orphan Therapeutics 49 anti CD# monoclonal 49 ARCOXIA 49 CD# antibody [001] 49 Elitek 49 CCR2 49 Ryder Sys Inc 49 WILEX 49 LymphoStat B TM 49 GPNMB 49 Aggrastat 49 EndoTAG TM 49 GammaCan 49 ProMune 49 DDP# 49 bendamustine 49 AVP #D# 49 EGRIFTA TM 49 depsipeptide 49 HCV polymerase inhibitors 49 CDK inhibitor 49 penicillin G benzathine 49 vidofludimus 49 Pyratine XR TM 49 PENNSAID 49 ONTAK 49 monoclonal 49 TNF alpha selectively neutralizing 49 ViroChem Pharma Inc. 49 Talabostat 49 Kahalalide F 49 INTEGRILIN R eptifibatide Injection 49 Spiegelmer ® 49 Transave 49 Tovaxin ® 49 PANC 49 HCV antiviral 49 Ziopharm 49 HCV polymerase 49 Protexia R 49 REBETOL combination therapy 49 gefitinib Iressa 49 Tarvacin 49 hepatitis C HCV 49 Orphan Drug designations 49 chemokine receptor 49 Firazyr 49 Olmesartan 49 sJIA 49 tramiprosate 49 Morquio 49 Phase Ib Clinical Trial 49 MoxDuo IR 49 Hemospan 49 Tipranavir 49 Genentech Roche Chugai 49 ULORIC 49 PDE# inhibitors 49 receptor tyrosine kinase inhibitor 49 Harbor BioSciences 48 Hypertriglyceridemia 48 interferon beta 1b 48 Tarmogen 48 Rebif ® 48 immunomodulating 48 generation NEUGENE 48 DAVANAT 48 MTP Ventures 48 nucleoside analog 48 PEG interferon 48 SinuNase TM 48 Synavive 48 PyratineXR 48 stated Michelle Berrey 48 HCl Tablets 48 Actimmune R 48 Ecallantide 48 Filgrastim 48 JVRS 48 mimetic peptide 48 R baclofen 48 surface antigen HBsAg 48 PXD# 48 BCR ABL inhibitors 48 cathepsin K inhibitor 48 beta secretase inhibitors 48 ara C 48 MYDICAR ® 48 DiObex 48 G#DT 48 Infergen R 48 inhibitor RG# 48 Phase #b/#a clinical 48 ganetespib 48 potent antiproliferative 48 voluntary prepayment 48 Alzhemed TM 48 IGF 1R inhibitor 48 ITAX 48 Alvesco R 48 Calixa Therapeutics 48 sodium glucose cotransporter 48 PT Ctfs Series 48 bendamustine HCl 48 Betaferon R 48 recombinant polyclonal antibody 48 GRENKE Group 48 cIAI 48 torezolid phosphate 48 delta isoform 48 GHN Agrispan 48 enfuvirtide 48 Ketotransdel 48 Vfend 48 BioMarck 48 Sublinox 48 Inflammatory bowel disease 48 Sinobiopharma 48 Cimzia ® certolizumab pegol 48 Aldex 48 MORAb 48 Neulasta ® 48 Qutenza ® 48 volociximab 48 highly selective endothelin 48 PrevOnco 48 ® interferon beta 48 CCX# 48 rFSH 48 peg interferon 48 AGS PSCA 48 Anavex #-# 48 glatiramer 48 oral candidiasis 48 Xencor XmAb 48 romidepsin novel 48 SANTE 48 SNT MC# 48 Femprox 48 trabectedin 48 AQ4N 48 cobiprostone 48 cardio renal 48 clobazam 48 TMC# [002] 48 null responder 48 pegylated IFN 48 ARIKACE ™ 48 Anti Bacterial Envelope 48 non nucleoside inhibitor 48 Zenvia ™ 48 Sensipar R 48 oral antiviral 48 cytoprotective 48 Rhein Biotech GmbH 48 Ascentage Pharma 48 HepeX B 48 JUVISTA 48 Anticalin R 48 AZD 48 epoprostenol sodium 48 AmBisome 48 CCR5 antagonist 48 CCR1 48 independent prognostic marker 48 Thrombin 48 ZADAXIN 48 certificateholders 48 Procoralan 48 rolapitant 48 Cethrin 48 thymalfasin 48 Granulocyte Colony Stimulating Factor 48 pathophysiological effects 48 Neurodex 48 MEK inhibitor 48 Immunotherapeutic 48 IFN α 48 receptor antagonists 48 Navelbine ® 48 gemcitabine cisplatin 48 ROCKET AF 48 Peg IFN 48 AZASITE 48 DISCUSSION AND POSSIBLE APPROVAL 48 INCB# [002] 48 YONDELIS 48 treatment naïve genotype 48 uPA 48 PentaStaph 48 Teplizumab 48 novel mTOR inhibitor 48 interleukin IL 48 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 48 StemEx 48 XL TechGroup 48 Panzem R 48 Interferon beta 48 * BIO Pte 48 omega interferon 48 cephalosporin antibiotic 48 nucleotide analogs 48 virosome 48 custirsen 48 TaiGen 48 Specifid 48 Ceplene histamine dihydrochloride 48 marketed pegylated interferons 48 leukemia AML 48 bexarotene 48 TYSABRI natalizumab 48 apaziquone 48 Trinam 48 Abbokinase 48 Can Fite 48 TargeGen 48 ibandronate 48 Reverset 48 NeuroSearch 48 MyVax ® 48 preclinically 48 fluconazole resistant 48 seropositivity 48 ibudilast 48 LIPO 48 diabetes mellitus T2DM 48 NeuVax 48 IPL# 48 metastatic hormone refractory 48 BiTE 48 CXA 48 zanolimumab 48 forodesine 48 Delafloxacin 48 EDEMA3 48 B2A 48 Acute Radiation Syndrome ARS 48 thrombopoietin 48 YERVOY 48 decitabine 48 Anticalin ® 48 AzaSite TM 48 Eraxis 48 GW# [003] 48 Symbollon 48 Raf kinase inhibitor 48 PEGylated interferon 48 Velcade bortezomib 48 IoGen 48 Clavis Pharma 48 BioNumerik 48 orally bioavailable mimics 48 R#/MEM # 48 CERE 48 Canvaxin TM 48 Immunitor 48 ridaforolimus 48 Civacir 48 antimetabolite 48 Viralytics 48 Plenaxis R 48 pegylated interferon alfa 48 comparator arm 48 cannabinor 48 subordinated promissory notes 48 VICTRELIS 48 daptomycin 48 Clolar ® 48 valopicitabine NM# 48 recombinant FVIII 48 Eloxatin R 48 Nasulin TM 48 calcineurin inhibitors 48 Exelixis XL# 48 B lymphocyte stimulator 48 Cloretazine 48 BOL # 48 Octreolin 48 novel histone deacetylase 48 MediWound 48 SMRI 48 somatostatin analogue 48 A1PI 48 hepatic encephalopathy 48 phase IIa clinical 48 PEG INTRON 48 Corautus 48 Cethrin R 48 Sezary syndrome 48 EGFR HER2 48 Gleevec imatinib mesylate 48 BiovaxID 48 Syntonix 48 EGb 48 TNFR1 48 Fodosine 48 Celmed 48 Ibis Therapeutics 48 Frova ® 48 Receivables Funding 48 sumatriptan DosePro 48 drug ISA# 48 Ascendiant 48 oral ridaforolimus 48 sitaxsentan 48 immunoconjugate 48 Gemzar ® 48 kallikrein 48 anti EGFR antibody 48 Thymosin Beta 4 48 fostamatinib 48 APTIVUS r 48 Aegis Therapeutics 48 macrolide 48 NV1FGF 48 HoFH 48 bremelanotide 48 TRAIL Receptor 48 metastatic malignant 48 Taligen Therapeutics 48 huN# DM1 48 lumiliximab 48 PIGF 48 channel ENaC 48 mGluR 48 Pharnext 48 Deferiprone 48 epithelial sodium 48 cell chronic lymphocytic 48 Natalizumab 48 DR #.#.# 48 OXIGON 48 cancer vaccine Norelin 48 prucalopride 48 Cerashield ™ 48 YONDELIS R 48 Genentech Rituxan 48 tanespimycin 48 registrational clinical 48 PDX pralatrexate 48 Zerenex ™ 48 Rapaflo 48 LAS# [002] 48 HT 2A 48 FUSILEV TM 48 TIMP 1 48 Chronic Hepatitis C 48 JunJing III 48 cariprazine 48 PSN# [001] 48 inhaled treprostinil 48 GRN# 48 gastric adenocarcinoma 48 Relieva 48 NS4A 48 TRX1 48 doripenem 48 genotypic resistance 48 Leukine ® 48 Aurexis 48 obatoclax 48 CRx 48 tipifarnib 48 Trastuzumab 48 Thiovir 48 Faropenem 48 MERREM IV 48 AZI 48 GFT# 48 Mucopolysaccharidosis 48 Phase IIb trials 48 Actimmune ® 48 BrachySil ™ 48 Axiogenesis 48 Ophthotech 48 Berinert 48 Argatroban 48 XmAb 48 receptor monoclonal antibody 48 Preferred Stock CUSIP 48 Somatuline Depot 47 ADP receptor antagonist 47 Symphony Icon 47 Troxatyl 47 Verstovsek 47 VALSTAR 47 plasma kallikrein inhibitor 47 Nuron Biotech 47 HCV protease inhibitor 47 AVINZA 47 udenafil 47 IFN alpha 2a 47 R5 tropic 47 OMNARIS Nasal Spray 47 Onco TCS 47 anti CD# antibody 47 Xeloda ® 47 dose escalation Phase 47 histone deacetylase HDAC 47 Pink Sheets NNVC 47 DYNEPO 47 polycythemia vera essential thrombocythemia 47 Junior Subordinated Notes 47 Tyzeka 47 eslicarbazepine acetate 47 polymerase inhibitor 47 BACM #-# 47 Pegasys peginterferon alfa 2a 47 Omacetaxine 47 TNFalpha 47 T2DM 47 XPF 47 Fanapt iloperidone 47 neurokinin 47 DEB# 47 LUMINATE 47 Vivaglobin 47 integrin inhibitor 47 targeting CD# 47 Engerix B 47 E1 INT 47 Azmacort R 47 Phase IIa trials 47 Solazed 47 DeveloGen 47 vaginal candidiasis 47 mGluR2 47 REYATAZ R 47 Elvitegravir 47 C. trachomatis 47 OncoVEX GM CSF 47 cinacalcet 47 Cethromycin 47 VitiGam 47 neurokinin 1 47 patented Bioral 47 pegylated liposomal doxorubicin 47 JUVISTA R Human 47 MAXY alpha 47 Subtype 47 Loramyc 47 EpiCeram TM 47 Infergen 47 RAPAFLO 47 Enkephalin 47 CAELYX 47 Cathepsin S 47 Paromomycin 47 JAK1 47 arsenic trioxide injection 47 refractory cutaneous T 47 Metastatic breast cancer 47 ALN HPN 47 FluCide 47 inotropic 47 systemic fungal infections 47 Bilive 47 humanized antibody 47 Azixa 47 T SPOT.TB 47 bowel syndrome IBS 47 VIAject ™ 47 Ogiene 47 Scancell 47 receptor agonist 47 epothilone 47 octreotide implant 47 HBV genotype 47 XL# XL# 47 davunetide intranasal AL 47 beta lactamases 47 rasagiline tablets 47 immunostimulatory 47 Nabi HB 47 DAS# CRP 47 Cycloset 47 TEMODAR 47 P#X# antagonist 47 MOVIPREP R 47 DermaVir Patch 47 Androxal TM 47 pegylated interferon alpha 47 TLK# 47 Gene Activated 47 Phase 1b clinical trials 47 chronic HCV infection 47 imatinib Gleevec 47 Vitality Re 47 e antigen HBeAg 47 celgosivir 47 cell malignancies 47 COLAZAL R 47 HuMax HepC TM 47 VSL # 47 metastatic CRC 47 Raptiva R 47 Increlex ® 47 PRT# 47 brostallicin 47 Xibrom TM 47 LGLS 47 KSP inhibitors 47 NitroMed BiDil 47 PEGINTRON TM 47 Gynazole 1 47 GLPG# 47 Proxinium TM 47 selective androgen receptor modulator 47 relapsing multiple sclerosis 47 ASONEP 47 EZN 47 glucan 47 oral talactoferrin 47 nanoviricides 47 lenalidomide Revlimid R 47 Chemokine 47 Certificados Bursatiles 47 galiximab 47 PERLANE 47 Urokinase 47 VELCADE melphalan 47 Tesmilifene 47 inhaled AAT 47 antithrombotic 47 peginterferon alfa 2a 47 Debio 47 NewLink 47 Zenyaku Kogyo 47 cidofovir 47 SETWrite 47 adenoviral 47 plecanatide 47 Personalized Immunotherapy 47 Polymer Microspheres 47 muraglitazar 47 PEGylated Fab fragment 47 olmesartan 47 tesetaxel 47 5HT 47 soluble tumor necrosis 47 rhIL 7 47 Ascend Therapeutics 47 Onrigin 47 AMPK activators 47 ELND# 47 MGd 47 sunitinib malate 47 TRISENOX 47 OMNARIS 47 epidermidis 47 plasmid DNA vaccine 47 abacavir Ziagen 47 thetreatment 47 voclosporin 47 Gafisa 47 AnGes MG Inc. 47 DACH platinum 47 Arisaph 47 μg dose 47 Tavocept 47 evaluating Actimmune 47 Functional Dyspepsia 47 ribavirin RBV 47 LTBI 47 Akela Pharma 47 Betaseron ® 47 endothelin receptor 47 PEG SN# 47 Zebinix R 47 VentiRx Pharmaceuticals 47 Phase III randomized controlled 47 Akt inhibitor 47 Chemokine Receptor 47 nucleotide analog